This case series followed seven individuals with bipolar disorder over three months of ketogenic metabolic therapy, assessing psychiatric, cardiometabolic, and patient-reported outcomes. Participants showed improved mood symptoms alongside varying reductions in obesity, prediabetes, and inflammatory markers.
New Results: First RCT for Schizophrenia & Bipolar Disorder. Learn more.